siRNA therapy shows promise for reducing genetic heart disease risk
In phase 1 trials, an experimental siRNA therapy has shown promise for reducing levels of a lipoprotein associated with a higher risk of premature heart disease. The treatment could help fight a form of the disease that can’t currently be treated throu… Continue reading siRNA therapy shows promise for reducing genetic heart disease risk